223 related articles for article (PubMed ID: 23311302)
1. Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.
Graves PM; Makita L; Susapu M; Brady MA; Melrose W; Capuano C; Zhang Z; Dapeng L; Ozaki M; Reeve D; Ichimori K; Kazadi WM; Michna F; Bockarie MJ; Kelly-Hope LA
Parasit Vectors; 2013 Jan; 6():7. PubMed ID: 23311302
[TBL] [Abstract][Full Text] [Related]
2. The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.
Mengistu B; Deribe K; Kebede F; Martindale S; Hassan M; Sime H; Mackenzie C; Mulugeta A; Tamiru M; Sileshi M; Hailu A; Gebre T; Fentaye A; Kebede B
Ethiop Med J; 2017; 55(Suppl 1):45-54. PubMed ID: 28878429
[TBL] [Abstract][Full Text] [Related]
3. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.
Koroma JB; Bangura MM; Hodges MH; Bah MS; Zhang Y; Bockarie MJ
Parasit Vectors; 2012 Jan; 5():10. PubMed ID: 22236419
[TBL] [Abstract][Full Text] [Related]
5. Progress on elimination of lymphatic filariasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y
Parasit Vectors; 2018 Jun; 11(1):334. PubMed ID: 29866207
[TBL] [Abstract][Full Text] [Related]
6. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
7. Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.
Rebollo MP; Bockarie MJ
Parasitology; 2014 Dec; 141(14):1912-7. PubMed ID: 25225828
[TBL] [Abstract][Full Text] [Related]
8. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
Mehta PK; Maharjan M
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
[TBL] [Abstract][Full Text] [Related]
9. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
Modi A; Gamit S; Jesalpura BS; Kurien G; Kosambiya JK
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005476. PubMed ID: 28369129
[TBL] [Abstract][Full Text] [Related]
10. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.
Simonsen PE; Derua YA; Magesa SM; Pedersen EM; Stensgaard AS; Malecela MN; Kisinza WN
Parasit Vectors; 2014 Nov; 7():507. PubMed ID: 25387483
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010-2015.
Dorkenoo MA; Bronzan R; Yehadji D; Tchalim M; Yakpa K; Etassoli S; Adjeloh P; Maman I; Sodahlon Y
Parasit Vectors; 2018 Apr; 11(1):244. PubMed ID: 29661231
[TBL] [Abstract][Full Text] [Related]
15. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
[TBL] [Abstract][Full Text] [Related]
16. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
17. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
[TBL] [Abstract][Full Text] [Related]
18. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
[TBL] [Abstract][Full Text] [Related]
19. The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.
de Souza DK; Ansumana R; Sessay S; Conteh A; Koudou B; Rebollo MP; Koroma J; Boakye DA; Bockarie MJ
Parasit Vectors; 2015 Sep; 8():488. PubMed ID: 26399968
[TBL] [Abstract][Full Text] [Related]
20. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
